Journals Progress in Neuro-psychopharma...

Progress in Neuro-psychopharmacology & Biological Psychiatry
Tong Zhang, Han Lv, Xinyu Zhao, Na Zeng, Ying Hui, Shuohua Chen, Ning Wu, Mingze Xu, YunTao Wu, Aijun Xing, Huijing Shi, Shun Zhang, Xiaoliang Liang, Yongxin Wang, Shouling Wu, Liufu Cui, Zhenchang Wang, Yanying Liu
BACKGROUND: Serum uric acid (SUA) is a major cause of cardiovascular and cerebrovascular diseases. Whether and to what extent the excess risk of enlarged perivascular spaces (EPVS) conferred by SUA is unknown. The study was conducted to investigate the association between SUA and EPVS in different brain regions. METHODS: Data are from Multi-modality medical imaging study based on Kailuan study (META-KLS) in this cross-sectional study. Participants were divided into five groups based on SUA levels, and EPVS in basal ganglia (BG), centrum semiovale (CSO) and midbrain (MB) was systematically assessed and divided into Low and High group...
April 3, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Francisca C Venegas, Daniela Rosas, Nicol Delgado, Camila Estay-Olmos, Patricio Iturriaga-Vásquez, Mario Rivera-Meza, Gonzalo E Torres, Georgina M Renard, Ramón Sotomayor-Zárate
While there is extensive research on alcohol dependence, the factors that make an individual vulnerable to developing alcoholism haven't been explored much. In this study, we aim to investigate how neonatal exposure to sex hormones affects alcohol intake and the regulation of the mesolimbic pathway in adulthood. The study aimed to investigate the impact of neonatal exposure to a single dose of testosterone propionate (TP) or estradiol valerate (EV) on ethanol consumption in adult rats. The rats were subjected to a two-bottle free-choice paradigm, and the content of dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC) in the nucleus accumbens (NAcc) was measured using HPLC-ED...
March 31, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Kaylene K A Scheil, Carla L Sánchez-Lafuente, Brady S Reive, Ciara S Halvorson, Jennifer Floyd, Hannah M O Reid, Jenessa N Johnston, Lisa E Kalynchuk, Hector J Caruncho
There is an urgent need for novel antidepressants, given that approximately 30% of those diagnosed with depression do not respond adequately to first-line treatment. Additionally, monoaminergic-based antidepressants have a substantial therapeutic time-lag, often taking months to reach full therapeutic effect. Ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist is the only current effective rapid-acting antidepressant, demonstrating efficacy within hours and lasting up to two weeks with an acute dose...
March 27, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Gabriel Casagrande Zabot, Eduarda Behenck Medeiros, Bárbara Machado Naspolini Macarini, Bruno Búrigo Peruchi, Gabriela Serafim Keller, Adrielly Vargas Lídio, Amanda Boaventura, Laura Ceolin de Jesus, Gustavo de Bem Silveira, Paulo Cesar Lock Silveira, Beatriz Costa Chede, Gislaine Zilli Réus, Josiane Budni
Alzheimer's disease (AD) and depression are inflammatory pathologies leading to increased inflammatory response and neurotoxicity. Therefore, this study aimed to evaluate the effect of the treatment with fluoxetine and/or galantamine and/or donepezil on the levels of proinflammatory and anti-inflammatory cytokines in a mixed animal model of depression and dementia. Adult male Wistar rats underwent chronic mild stress (CMS) protocol for 40 days were subjected to stereotaxic surgery for intra-hippocampal administration of amyloid-beta (Aꞵ) peptide or artificial cerebrospinal fluid (ACSF) to mimic the dementia animal model...
March 27, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Bianca B Bellini, Jaqueline R Scholz, Tania O Abe, Debora Arnaut, Serena Tonstad, Rodrigo L Alberto, Patricia V Gaya, Iana R A de Moraes, Manoel J Teixeira, Marco A Marcolin
INTRODUCTION: A substantial proportion of smokers wishing to quit do not stop smoking when using current therapies to aid cessation. Magnetic pulses to specific brain areas designated as transcranial magnetic stimulation may modulate brain activity and thereby change chemical dependencies. Deep transcranial magnetic stimulation (dTMS) with the H4 coil stimulates neuronal pathways in the lateral prefrontal cortex and insula bilaterally, areas involved in tobacco addiction. OBJECTIVE: To evaluate the efficacy and safety of dTMS with T4 coil in smoking cessation...
March 24, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
P Sampedro-Piquero, F Buades-Sitjar, A Capilla, C Zancada-Menéndez, A González-Baeza, R D Moreno-Fernández
The identification of the risk factors of alcohol consumption in youths is crucial for early interventions focused on reducing harmful alcohol use. In our study, 82 college students (40 healthy control (CO group) and 42 with risky alcohol use (RAU group) determined by AUDIT questionnaire) between the ages of 18 and 25 years underwent a comprehensive neuropsychological assessment covering emotional and cognitive functioning. Their resting-state activity was also recorded with an EEG for 10 min with their eyes open (EO) and 10 min with their eyes closed (EC) and analyzed using the Fitting Oscillations & One-Over-F (FOOOF) paradigm...
March 19, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Yue Zhang, Xian-Qiang Zhang, Wei-Pan Niu, Meng Sun, Yanan Zhang, Ji-Tao Li, Tian-Mei Si, Yun-Ai Su
Multiple lines of evidence suggest that the trace amine-associated receptor 1 (TAAR1) holds promise as a potential target for stress-related disorders, such as treating major depressive disorder (MDD). The role of TAAR1 in the regulation of adult neurogenesis is recently supported by transcriptomic data. However, it remains unknown whether TAAR1 in dentate gyrus (DG) mediate chronic stress-induced negative effects on hippocampal plasticity and related behavior in mice. The present study consisted of a series of experiments using RNAscope, genetic approaches, behavioral tests, immunohistochemical staining, Golgi-Cox technique to unravel the effects of TAAR1 on alterations of dentate neuronal plasticity and cognitive function in the chronic social defeat stress model...
March 19, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Daniela Maria Escobar-Espinal, Airam Nicole Vivanco-Estela, Núbia Barros, Maurício Dos Santos Pereira, Francisco Silveira Guimaraes, Elaine Del Bel, Glauce C Nascimento
Trigeminal neuralgia (TN) is an intense and debilitating orofacial pain. The gold standard treatment for TN is carbamazepine. This antiepileptic drug provides pain relief with limited efficacy and side effects. To study the antinociceptive potential of cannabidiol (CBD) and its fluorinated analog PECS-101 (former HUF-101), we induced unilateral chronic constriction injury of the infraorbital nerve (IoN-CCI) in male Wistar rats. Seven days of treatment with CBD (30 mg/kg), PECS-101 (3, 10, and 30 mg/kg), or carbamazepine (10 and 30 mg/kg) reduced allodynia and hyperalgesia responses...
March 19, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Shusheng Wu, Yuye Yin, Longfei Du
Major depressive disorder (MDD) is a recurrent, persistent, and debilitating neuropsychiatric syndrome with an increasing morbidity and mortality, representing the leading cause of disability worldwide. The dysregulation of immune systems (including innate and adaptive immune systems) has been identified as one of the key contributing factors in the progression of MDD. As the main force of the humoral immunity, B cells have an essential role in the defense against infections, antitumor immunity and autoimmune diseases...
March 13, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Han Qin, Miao Yu, Nianjiao Han, Meilin Zhu, Xia Li, Jing Zhou
Postpartum depression (PPD) is a serious mental health problem that can negatively affect future generations. BDNF/AKT/mTOR signaling in the frontal lobe and hippocampus in mice is associated with depression, but its role in mice with PPD and their offspring is unknown. This study was aimed at investigating the effects of esketamine (ESK), a drug approved for treatment of refractory depression, on the BDNF/AKT/mTOR pathway in mice with PPD and their offspring. A model of chronic unpredictable mild stress with pregnancy was used...
March 13, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Maria T Secara, Lindsay D Oliver, Julia Gallucci, Erin W Dickie, George Foussias, James Gold, Anil K Malhotra, Robert W Buchanan, Aristotle N Voineskos, Colin Hawco
BACKGROUND: Individuals with schizophrenia spectrum disorders (SSD) often demonstrate cognitive impairments, associated with poor functional outcomes. While neurobiological heterogeneity has posed challenges when examining social cognition in SSD, it provides a unique opportunity to explore brain-behavior relationships. The aim of this study was to investigate the relationship between individual variability in functional connectivity during resting state and the performance of a social task and social and non-social cognition in a large sample of controls and individuals diagnosed with SSD...
March 12, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Chang Hyeon Kong, Jin Woo Lee, Mijin Jeon, Woo Chang Kang, Min Seo Kim, Keontae Park, Ho Jung Bae, Se Jin Park, Seo Yun Jung, Su-Nam Kim, Benjamin Kleinfelter, Ji-Woon Kim, Jong Hoon Ryu
Post-traumatic stress disorder (PTSD) is a mental illness that can occur in individuals who have experienced trauma. Current treatments for PTSD, typically serotonin reuptake inhibitors, have limited effectiveness for patients and often cause serious adverse effects. Therefore, a novel class of treatment with better pharmacological profile is necessary. D-Pinitol has been reported to be effective for depression and anxiety disorders, but there are no reports associated with PTSD. In the present study, we investigated the effects of D-pinitol in a mouse model of PTSD induced by a single prolonged stress (SPS) protocol...
March 9, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Synthia Guimond, Tamsyn E Van Rheenen
No abstract text is available yet for this article.
March 6, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Zhi-Hua Wang, Zhi-Ping Xie, Zhi-Xiong Zhang, Wu Zhou, Bo-Yu Guo, Mei-Hua Li
BACKGROUND: Exosomes can penetrate the blood-brain barrier for material exchange between the peripheral and central nervous systems. Differences in exosome contents could explain the susceptibility of different individuals to depression-like behavior after traumatic spinal cord injury (TSCI). METHODS: Hierarchical clustering was used to integrate multiple depression-related behavioral outcomes in sham and TSCI rats and ultimately identify non-depressed and depressed rats...
March 2, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Tao Pang, Ning Ding, Yilu Zhao, Jingjing Zhao, Li Yang, Suhua Chang
Cumulative evidence has showed the deficits of inhibitory control in patients with attention deficit hyperactivity disorder (ADHD), which is considered as an endophenotype of ADHD. Genetic study of inhibitory control could advance gene discovery and further facilitate the understanding of ADHD genetic basis, but the studies were limited in both the general population and ADHD patients. To reveal genetic risk variants of inhibitory control and its potential genetic relationship with ADHD, we conducted genome-wide association studies (GWAS) on inhibitory control using three datasets, which included 783 and 957 ADHD patients and 1350 healthy children...
February 29, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Jiaqi Wang, Ruolei Gu, Xiangzhen Kong, Shenghua Luan, Yu L L Luo
Impulsivity is related to a host of mental and behavioral problems. It is a complex construct with many different manifestations, most of which are heritable. The genetic compositions of these impulsivity manifestations, however, remain unclear. A number of genome-wide association studies (GWAS) and post-GWAS analyses have tried to address this issue. We conducted a systematic review of all GWAS and post-GWAS analyses of impulsivity published up to December 2023. Available data suggest that single nucleotide polymorphisms (SNPs) in more than a dozen of genes (e...
February 29, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Nahathai Limveeraprajak, Sirapop Nakhawatchana, Apidsada Visukamol, Christsanutth Siripakkaphant, Sirijit Suttajit, Manit Srisurapanont
This systematic review and meta-analysis aimed to assess the efficacy and acceptability of S-adenosyl-L-methionine (SAMe) in treating depression. We conducted a comprehensive search of PubMed, Embase, Cochrane Library, and from inception to July 3, 2023, identifying randomized controlled trials comparing SAMe with placebo or antidepressants (ADs). We synthesized data on reduced depressive symptoms (efficacy) and overall dropout rates (acceptability) using a random-effects model for pairwise frequentist meta-analysis...
February 27, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Jenny L Wiley, Julie A Marusich, Bruce E Blough, Ojas Namjoshi, Marcus Brackeen, Luli R Akinfiresoye, Teneille D Walker, Cassandra Prioleau, Daniel G Barrus, Thomas F Gamage
BACKGROUND: The cannabis plant contains several cannabinoids, and many terpenoids that give cannabis its distinctive flavoring and aroma. Δ9 -Tetrahydrocannabinol (Δ9 -THC) is the plant's primary psychoactive constituent. Given the abuse liability of Δ9 -THC, assessment of the psychoactive effects of minor cannabinoids and other plant constituents is important, especially for compounds that may be used medicinally. This study sought to evaluate select minor cannabinoids and terpenes for Δ9 -THC-like psychoactivity in mouse Δ9 -THC drug discrimination and determine their binding affinities at CB1 and CB2 receptors...
February 27, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Abdulqadir J Nashwan, Syeda Tayyaba Rehan, Laiba Imran, Samina Ghulam Abbas, Sara Fahim Khan
Postpartum depression (PPD) poses a major threat to maternal mental health and wellbeing while also adversely affecting the mother's relationship with her baby, leading to significant repercussions that may hinder the growth and cognitive development of the child. For decades, antidepressants have been the mainstay of treating PPD; however, recent evidence suggests that antidepressants are not as effective as they are believed to be and there is a dire need to explore new treatment options. In 2023, a breakthrough in treating PPD emerged with the recent FDA approval of zuranolone, a gamma-aminobutyric acid (GABAA ) receptor selective positive allosteric modulator...
February 25, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Zhenzhen Huo, Rong Zhang, Zhiyi Chen, Junye Xu, Ting Xu, Tingyong Feng
Procrastination has adverse consequences across cultural contexts. Behavioral research found a positive correlation between punishment sensitivity and procrastination. However, little is known about the neural substrates underlying the association between them. We employed voxel-based morphometry (VBM) and resting-state functional connectivity (RSFC) methods to address this issue with two independent samples. In Sample 1, behavioral results found that punishment sensitivity was positively related to procrastination...
February 20, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.